Treventis' Incubator/Accelerator Round

Treventis raised a round of funding on February 01, 2017. Investors include JLabs.

Treventis is a biotechnology company focused on therapeutics and diagnostics for protein misfolding diseases. The company has leveraged a drug design platform to synthesize a class of organic drug-lik…

Articles about Treventis' Incubator/Accelerator Round: